Kathleen Dorritie
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma (NCT06050512) | Kathleen Dorritie | 2023-10-02 |
| Stem Cell Transplant in Patients With Severe Sickle Cell Disease (NCT03421756) | Kathleen Dorritie | 2018-03-29 |
Track Kathleen Dorritie automatically
Every clearance here is in the API, with alerts when new ones post.